Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131572) titled 'The impact of multi-omics integrated with artificial intelligence technology on the occurrence and development of macrovascular complications in type 2 diabetes mellitus' on Sept. 4.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Kunming Medical University
Condition:
Type 2 diabetes mellitus complicated with macrovascular complications.
Intervention:
Group of type 2 diabetes mellitus subjects without macrovascular complications.:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-15
Target Sample Size: Gr...